Is vaginal metronidazole (Flagyl) safe to use during the second trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vaginal Metronidazole Use in the Second Trimester of Pregnancy

Yes, vaginal metronidazole can be safely used during the second trimester of pregnancy for conditions such as bacterial vaginosis (BV). 1 The CDC specifically recommends that while metronidazole is contraindicated in the first trimester, it can be used during the second and third trimesters of pregnancy.

Safety Profile and Recommendations

  • During the second trimester, both oral and vaginal metronidazole formulations are considered acceptable treatment options 2, 1
  • The CDC guidelines specifically state that "during the second and third trimesters of pregnancy, oral metronidazole can be used, although the vaginal metronidazole gel or clindamycin cream may be preferable" 2
  • Vaginal application may be preferred over oral administration as it provides targeted therapy with potentially lower systemic exposure 1

Treatment Options for Bacterial Vaginosis in Pregnancy

For bacterial vaginosis during pregnancy, the following options are available:

  • First trimester: Clindamycin vaginal cream is preferred due to contraindication of metronidazole 2
  • Second and third trimesters:
    • Oral metronidazole 500 mg twice daily for 7 days 1
    • Vaginal metronidazole gel 0.75%, one full applicator (5g) intravaginally once daily for 5 days 1

Clinical Considerations and Cautions

Efficacy

  • Treatment of BV during pregnancy is important as it has been associated with adverse pregnancy outcomes including premature rupture of membranes, preterm labor, and preterm delivery 2, 1
  • The American College of Obstetricians and Gynecologists recommends screening and treating high-risk asymptomatic pregnant women (those with history of previous preterm birth) for BV, preferably in the early second trimester 1

Potential Risks

While most evidence supports safety, some conflicting research exists:

  • A 2021 study found metronidazole was associated with a 70% increased risk of spontaneous abortion, though this may be confounded by the severity of the underlying infection 3
  • A 2023 animal study raised concerns about potential maternal and fetal hepatotoxicity at high doses 4, though human studies have not confirmed these findings

Important Clinical Pitfalls to Avoid

  1. Do not use metronidazole in the first trimester - it is contraindicated during this period 2, 1
  2. Warn patients about alcohol interaction - patients must avoid alcohol during treatment and for 24 hours afterward to prevent disulfiram-like reactions 1
  3. Be cautious with high-risk pregnancies - consider follow-up evaluation 1 month after treatment completion for high-risk pregnant women 1
  4. Do not use metronidazole as the sole antibiotic in high-risk populations - A 2007 study suggested that metronidazole when used alone in the second trimester might be associated with a higher risk of preterm delivery in high-risk populations 5

Conclusion on Safety

The most recent and authoritative guidelines from the CDC support the use of vaginal metronidazole during the second trimester of pregnancy 2, 1. A prospective controlled cohort study confirmed that metronidazole does not represent a major teratogenic risk in humans when used in recommended doses 6.

References

Guideline

Metronidazole Use During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The safety of metronidazole in pregnancy.

Health care for women international, 2021

Research

The effect of second-trimester antibiotic therapy on the rate of preterm birth.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.